Chaotic, Disorganized, and Mismanaged - Scientist bei Zymeworks: Mitarbeiterbewertung

1.0
27. Mai 2022
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Zanidatamab is an excellent asset

Kontras

- Talented & experienced group of scientists that developed Zanidatamab are no longer at Zymeworks - Senior Scientific leadership does not have the necessary drug development experience - Success of pipeline projects doesn't matter, company is treading water to get to a sale - CEO has no history developing medicine or building companies. His history is dominated by breaking apart and selling assets. - Former CFO, at least partly responsible for the cratering of the company, is allowed to remain and transition to COO. - Company still talks about its values as though they determine corporate behavior

Mehr Bewertungen zu Zymeworks entdecken

5.0
15. Jan. 2025
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Good discipline nice work experience

Kontras

No bad experience it was good

4.0
10. Apr. 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Good mangement okay salary good

Kontras

Nothing to say from me

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle